METASTATIC SOFT-TISSUE SARCOMA
Clinical trials for METASTATIC SOFT-TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOFT-TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC SOFT-TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink Hard-to-Treat sarcomas
Disease control Recruiting nowThis early-phase trial tests whether adding the experimental drug zanzalintinib to two immunotherapy drugs (ipilimumab and nivolumab) is safe and can shrink tumors in people with metastatic soft tissue sarcoma. About 18 adults who have already tried 1 to 3 prior treatments will r…
Matched conditions: METASTATIC SOFT-TISSUE SARCOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for sarcoma patients: drug combo aims to shrink tumors
Disease control Recruiting nowThis study tests a new two-drug treatment for people with advanced soft tissue sarcomas (cancers of the muscles, fat, or other connective tissues). The drugs, abemaciclib and gemcitabine, work together to stop cancer cells from growing. The trial will compare this new combo to th…
Matched conditions: METASTATIC SOFT-TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Lung-Directed chemo spray aims to stop cancer spread
Disease control Recruiting nowThis study tests a procedure called pulmonary suffusion, which delivers the chemotherapy drug cisplatin directly to the lungs through a minimally invasive method. The goal is to control any remaining cancer cells after surgery or ablation in patients with sarcoma or colorectal ca…
Matched conditions: METASTATIC SOFT-TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Engineered immune cells take on sarcoma in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called attIL12-TIL for people with advanced or metastatic soft tissue and bone sarcoma. The therapy uses a patient's own tumor-fighting immune cells, modified to better target and attack cancer. The study first finds a safe dose, then …
Matched conditions: METASTATIC SOFT-TISSUE SARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for rare sarcoma: targeted drug ADCE-D01 enters human trials
Disease control Recruiting nowThis study tests a new drug called ADCE-D01 in people with soft tissue sarcoma that has spread or cannot be removed by surgery. The drug is designed to find and attack cancer cells while leaving healthy cells alone. The trial will check safety, the right dose, and whether it shri…
Matched conditions: METASTATIC SOFT-TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC